• English
  • Eesti

    EudraVigilance downtown period 8 to 22 November 2017

    Printer-friendly version

    The European Medicines Agency will be releasing the new EudraVigilance system for the submission of ICSRs to the EudraVigilance Post-authorisation module (EVPM) and the EudraVigilance Clinical Trial Module (EVCTM) on 22 November 2017 at 11:00 Estonian time. 

    Marketing authorisation holders and clinical trial sponsors must not send any ICSRs, SUSARs and XEVMPRM messages to EudraVigilance from 8 November (02:00 Estonian time) to 22 November (11:00 Estonian time). Any messages sent during this period will be deleted.

    This information is applicable as well for veterinary side.

    More information on EMA website.